Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

After More Than 150 Years, Recent Progress in Atherosclerosis Treatment

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    For more than 150 years, medical researchers have known that atherosclerosis had an inflammatory component. But Dr. Lawrence Cohen, president and CEO of VIA Pharmaceuticals tells host Bruce Japsen of the Chicago Tribune why there has not been anything done about it.

Recommended
Details
Presenters
Comments
  • Overview

    For more than 150 years, medical researchers have known that atherosclerosis had an inflammatory component. But Dr. Lawrence Cohen, president and CEO of VIA Pharmaceuticals tells host Bruce Japsen of the Chicago Tribune why there has not been anything done about it.

Schedule11 Dec 2024